The role of H2 receptor antagonist premedication in pregnant day care patients
- PMID: 3899317
- DOI: 10.1007/BF03010793
The role of H2 receptor antagonist premedication in pregnant day care patients
Abstract
In a randomised study of 132 pregnant outpatients, the effect on gastric volume and pH of oral premedication with a single dose of an H2 antagonist was investigated. Either cimetidine 400 mg (n = 33), or ranitidine 150 mg (n = 33), were given 90 to 120 minutes before scheduled surgery. Mean pH was significantly higher in cimetidine (5.0) and ranitidine (5.2) groups, and mean volume was significantly lower in cimetidine (13.2 ml) and ranitidine (11.1 ml) groups compared with 66 untreated patients (pH 1.6, volume 22.1 ml). A gastric pH less than or equal to 2.5 was found in 97 per cent of unpremedicated patients and 35 per cent of these patients also had a gastric volume greater than or equal to 25 ml. Eighty-three per cent of patients received their premedication within 75-200 minutes of surgery. Patients premedicated within that range had a significantly lower incidence of either a gastric pH less than or equal to 2.5 or a volume greater than or equal to 25 ml (p less than 0.01). Both cimetidine and ranitidine significantly reduced the number of patients with these risk factors. Four patients, however, in the cimetidine group had both a pH less than or equal to 2.5 and a volume greater than or equal to 25 ml. Pharmacological manipulation of the gastric environment does not prevent aspiration and clearly cannot be substituted for careful airway management and vigilance on the part of the anaesthetist. However, premedication of pregnant outpatients with a single, oral dose of an H2 antagonist is a simple, inexpensive, safe and effective way of reducing the risk of a severe aspiration pneumonitis.
Similar articles
-
Single-dose intravenous H2 blocker prophylaxis against aspiration pneumonitis: assessment of drug concentration in gastric aspirate.AANA J. 1989 Jun;57(3):238-43. AANA J. 1989. PMID: 2773628 Clinical Trial.
-
Evaluation of ranitidine as an oral antacid in outpatient anesthesia.South Med J. 1985 Jul;78(7):818-22. doi: 10.1097/00007611-198507000-00012. South Med J. 1985. PMID: 4012378 Clinical Trial.
-
Pre-operative intramuscular ranitidine and cimetidine. Double blind comparative trial, effect on gastric pH and volume.Anaesthesia. 1985 Mar;40(3):242-5. Anaesthesia. 1985. PMID: 3887977 Clinical Trial.
-
Prophylaxis for aspiration pneumonitis.Can Anaesth Soc J. 1986 May;33(3 Pt 2):S47-53. doi: 10.1007/BF03019156. Can Anaesth Soc J. 1986. PMID: 2872952 Review. No abstract available.
-
The effect of ranitidine versus proton pump inhibitors on gastric secretions: a meta-analysis of randomised control trials.Anaesthesia. 2009 Jun;64(6):652-7. doi: 10.1111/j.1365-2044.2008.05861.x. Anaesthesia. 2009. PMID: 19453319 Review.
Cited by
-
Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.Drugs. 1989 Jun;37(6):801-70. doi: 10.2165/00003495-198937060-00003. Drugs. 1989. PMID: 2667937 Review.